Jingwen Luo
-
- Nanoparticle-Based Drug Delivery 2
- Hepatology top 10%
- Liver physiology and pathology 2
-
- Nanoplatforms for cancer theranostics 3
-
- Liver Disease Diagnosis and Treatment 2
-
- Immunotherapy and Immune Responses 2
-
- Building Energy and Comfort Optimization 1
-
- Advancements in Transdermal Drug Delivery 1
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- Tao GongLixin MaZhirong ZhangPei ZhangTing ZhaoMengdi JiaYao FuWenhao Li
- Cited by
- BiomaterialsHepatologyPhysiology
- Journals
- Journal of Drug Delivery Science and Technology (2 papers)Carbohydrate Polymers (2 papers)Cellular and Molecular Immunology (1 paper)
- Partner nations
- China
In The Last Decade
Jingwen Luo
12 papers receiving 343 citations
Peers
Comparison fields: 5 of 78
- Biomaterials 89
- Hepatology 54
- Physiology 20
- Cell Biology 53
- Molecular Medicine 14
Countries citing papers authored by Jingwen Luo
This map shows the geographic impact of Jingwen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwen Luo more than expected).
Fields of papers citing papers by Jingwen Luo
This network shows the impact of papers produced by Jingwen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwen Luo. The network helps show where Jingwen Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingwen Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 38 | |
| 6 | 2022 | 31 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 39 | |
| 10 | 2020 | 61 | |
| 11 | 2019 | 31 | |
| 12 | 2019 | 118 |
About Jingwen Luo
Jingwen Luo is a scholar working on Pharmaceutical Science, Hepatology and Physiology, having authored 12 papers that have together received 346 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Liver physiology and pathology (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Immunotherapy and Immune Responses (2 papers), Building Energy and Comfort Optimization (1 paper), Advancements in Transdermal Drug Delivery (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Biomaterials (89 citations), Hepatology (54 citations) and Physiology (20 citations). Jingwen Luo has collaborated with scholars based in China. Frequent co-authors include Tao Gong, Lixin Ma, Zhirong Zhang, Pei Zhang, Ting Zhao, Mengdi Jia, Yao Fu, Wenhao Li, Yanming Dong and Zhiwei Zhang. Their work appears in journals such as Journal of Drug Delivery Science and Technology, Carbohydrate Polymers, Cellular and Molecular Immunology, Acta Biomaterialia and Energy Sources Part A Recovery Utilization and Environmental Effects.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.